FDA authorizes drug for those who cannot be vaccinated against Covid-19


Evusheld is not a substitute for the vaccine, as the FDA emphasizes, so it must be applied in specific circumstances.

Photo: SIMON MAINA / AFP / Getty Images

The US Food and Drug Administration (FDA) approved the emergency use of an Astrazeneca drug to prevent the spread of coronavirus intended for those who due to their medical condition cannot get a vaccine.

It’s a statement, The FDA explains that this product is only authorized for non-infected or exposed people who have an immune system that does not allow them to be vaccinated or a history of adverse reactions to vaccines.

“Vaccines have proven to be the best defense against Covid-19, but there are immunosuppressed individuals who may not see an increased immune response given by the vaccine and who need a prevention alternative “Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said in the statement.

The medicine, called Evusheld, consists of a combination of two monoclonal antibodies and is given in two consecutive injections., one per antibody.

It is indicated for certain adults and pediatric patients over 12 years of age weighing at least 40 kilograms.

Evusheld is not authorized for the treatment of Covid-19 or for prevention after possible exposure to the virus. It is also not a substitute for the vaccine, as the FDA emphasizes.

Read more:
Federal judge blocks Biden’s Covid-19 vaccine mandate for federal workers
Faced with a rebound in hospitalizations for COVID-19, they warn that getting vaccinated is critical
More contagious but less deadly? What is known about the Omicron variant at the moment